Trikafta (elexacaftor/tezacaftor/ivacaftor) prior authorization denied appeal
CFTR modulator
Typical PA criteria
- Cystic fibrosis diagnosis
- At least one F508del mutation or other approved mutation
- Age 2 or older
Why your PA was denied
- Mutation not on approved list
- Age criteria not met
Evidence that overturns the denial
- ✓Genetic test result
- ✓CF specialist letter
- ✓FDA label citation
Mutation list expands periodically; check the current FDA label if the denial cites an unapproved mutation.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Trikafta (elexacaftor/tezacaftor/ivacaftor) prior authorization denied?+
The most common reasons are: Mutation not on approved list; Age criteria not met. Your denial letter names the specific criteria you did not meet.
How do I appeal a Trikafta (elexacaftor/tezacaftor/ivacaftor) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Trikafta (elexacaftor/tezacaftor/ivacaftor) denial?+
Genetic test result; CF specialist letter; FDA label citation.
What if the plan excludes Trikafta (elexacaftor/tezacaftor/ivacaftor) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)